Koning Vera 3D Breast CT: Dense Breasts, Clear Answers

Комментарии · 5 Просмотры

Dense breast tissue on your mammogram? Koning Vera 3D breast CT delivers the clarity standard imaging can't — no compression, true 3D, real answers.

The Dense Breast Problem Nobody Talks to You About

You get your mammogram. The report comes back and buried somewhere in the clinical language is a line you may not have expected: dense breast tissue. Your results may be normal — or there may be something there that the imaging simply couldn't fully evaluate. Either way, you're being sent home with a qualified answer instead of a clear one.

This is the experience of roughly half of women in the United States who undergo mammography. Dense breast tissue is extremely common. It's also one of mammography's most significant limitations — not because of any fault with the technology, but because of a basic physical reality: dense tissue and tumors both appear white on a mammogram. One can hide the other.

Knowing you have dense breasts isn't the same as knowing your breasts are healthy. And for women who've been in that position — holding a "probably normal" result when what they needed was a definitive one — the gap between those two things can feel enormous.

Koning Vera 3D breast CT was built to close that gap.

Why Density Changes Everything in Breast Imaging

Breast tissue comes in four categories of density, from almost entirely fatty to extremely dense. Dense tissue isn't abnormal — it's simply a characteristic of how that person's breast is composed. But it has direct implications for how effectively a mammogram can detect abnormalities.

In fatty breast tissue, a tumor or mass appears as a distinct white shape against a darker background. It's relatively easy to see. In dense breast tissue, the entire field is lighter — and any abnormality has to be distinguished against a background that looks almost identical. Radiologists describe this as trying to find a snowball in a snowstorm.

The consequence is twofold: dense tissue can hide real abnormalities, and it can create the appearance of concerns that turn out to be tissue, not pathology. Both outcomes lead to callbacks, additional imaging, anxiety, and for some women, unnecessary biopsies.

True 3D imaging addresses this at the structural level. When you can see all of the tissue in three dimensions — separating overlapping structures and viewing the breast from every angle — density stops being an obstacle to clarity and becomes simply a characteristic of the tissue being imaged.

How Koning Vera 3D Breast CT Works: The Technology Behind the Results

The Koning Vera system is a dedicated breast CT platform — which means it was designed specifically for breast imaging, not adapted from a general-purpose CT scanner. That distinction matters clinically. The geometry of the system, the detector design, and the image reconstruction algorithms are all optimized for the specific challenge of visualizing breast tissue with high contrast and exceptional spatial resolution.

During a scan, the patient lies face-down on a padded table with the breast positioned in the imaging aperture. There is no compression, no plates, no physical discomfort. The system rotates around the breast in a complete 360-degree arc, capturing the data needed to reconstruct a true volumetric 3D image in approximately ten seconds per breast. A bilateral exam — both breasts — is completed in under five minutes.

The resulting images give the radiologist a complete three-dimensional view of the breast tissue. Masses, calcifications, asymmetries, and architectural distortions can be evaluated in volumetric space rather than in projection. The clinical information is simply richer — and that richness translates directly into more confident, more accurate clinical decision-making.

Who Should Consider This Technology

The breast ct scan at Gnosis for Her is currently used as a diagnostic imaging tool — meaning it's intended as a complement to mammography, not a replacement for annual screening. It's the next step when standard imaging raises questions that need better answers. Women who should consider this technology include those who:

Have been told they have dense breast tissue and want clearer imaging. Have received a callback after a mammogram and are waiting for follow-up imaging. Have a BI-RADS 3 finding that's being monitored with six-month follow-up scans. Have breast implants that limit the effectiveness of conventional mammography. Carry BRCA1 or BRCA2 gene mutations and require supplemental imaging beyond standard screening. Are experiencing breast symptoms — a lump, nipple changes, localized pain — that haven't been fully explained by existing imaging. Find traditional mammography uncomfortable or impossible to tolerate due to sensitivity or physical limitations.

This is a meaningful range of clinical situations. In all of them, the common thread is a need for greater diagnostic clarity — and a recognition that standard imaging, as valuable as it is, isn't always enough.

The FDA Approval Behind the Technology

When you're evaluating a medical imaging technology, regulatory status is one of the most important signals of safety and clinical validity. Koning Vera holds FDA Premarket Approval — designated as a PMA, which is the highest level of regulatory clearance the FDA grants to medical devices. This is not a 510(k) clearance based on substantial equivalence to a prior device. It's approval based on direct evidence of safety and effectiveness.

The PMA covers both breast CT imaging and 3D-guided biopsy. For women and clinicians considering this technology, that clearance status provides a substantive foundation of confidence. The American Medical Association has also assigned six dedicated CPT codes for breast CT as of January 2021, reflecting the clinical community's recognition of this as a distinct and valid imaging modality.

The Radiation Picture: Numbers Worth Knowing

Radiation is a reasonable concern when evaluating any medical imaging technology, and the numbers here are worth understanding clearly.

The non-contrast Koning Vera breast ct scan delivers approximately 0.7 mSv of radiation. The average American's annual background radiation exposure — from cosmic rays, soil, building materials, and food — is approximately 3.1 mSv. The breast CT scan at Gnosis for Her delivers about 75% less radiation than that natural yearly exposure, and is comparable in dose to a standard 2D mammogram.

For biopsies, the comparison to conventional methods is even more favorable: the Koning Vera system uses approximately 50% less radiation than traditional stereotactic biopsy approaches.

For women who have been weighing the decision of whether to pursue additional imaging, this safety profile removes one significant concern from the equation.

What the Mobile Model Means for Access

Gnosis for Her operates through a mobile care unit — a purpose-built vehicle that brings the Koning Vera 3D breast CT directly to community locations across Southern California. This isn't a logistical detail. It's a philosophical commitment to health equity.

Advanced diagnostic breast imaging has historically been available primarily through large hospital systems and specialty imaging centers. Women with transportation challenges, work schedule constraints, or who simply live outside the geographic footprint of these facilities have faced real barriers to accessing the technology that's now standard at well-resourced institutions.

A mobile platform removes those barriers. The Gnosis for Her unit comes to the community — to locations that are already accessible to the women who live and work there. The technology inside is identical. The radiologist reviewing the images is board-certified. The results are delivered securely, typically within 72 hours when prior imaging is available.

Scheduling, Cost, and What to Expect

Booking a scan with Gnosis for Her requires a provider referral, as diagnostic imaging in California must be ordered by a licensed medical provider. If you don't have a current provider or need to be seen quickly, Gnosis for Her's physician partner Karis Healthcare offers a telehealth evaluation and can provide the necessary referral if appropriate.

The cost for a self-pay scan is $499, with a $20 reservation fee at scheduling that applies to the total. FSA and HSA accounts are eligible for reimbursement. Insurance acceptance is in active development. The scan itself is quick, comfortable, and conducted in an environment designed to feel supportive rather than clinical.

Results are read by a board-certified radiologist and shared with both patient and physician — clearly, promptly, and with the context needed to understand what comes next.

Комментарии